Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy

Journal of Nuclear Medicine

Volumn 39, Issue 3, 1998, Pages 390-396

  Tadamura, Eiji ^a   Kudoh, Takashi ^b   Hattori, Naoya ^b   Inubushi, Masayuki ^b   Magata, Yasuhiro ^b   Konishi, Junji ^b   Matsumori, Akira ^b   Nohara, Ryuji ^b   Sasayama, Shigetake ^b   Yoshibayashi, Muneo ^b   Tamaki, Nagara ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

BMIPP; Glucose metabolism; Hypertrophic cardiomyopathy; Oxidative metabolism; PET

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; GLUCOSE; OXYGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCULATION; CLEARANCE; CLINICAL ARTICLE; FATTY ACID TRANSPORT; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACETATES; ADULT; CARBON RADIOISOTOPES; CARDIOMYOPATHY, HYPERTROPHIC; FATTY ACIDS; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MYOCARDIUM; OXYGEN CONSUMPTION; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031929825     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Bing RJ. Cardiac metabolism. Physiol Rev 1965;45:171-213.
2. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972;15:289-329.
3. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 1974;36:413-459.
4. Opie LH, Owen P, Lubbe W. Estimated glycolytic flux in infarcting heart. Recent Adv Stud Cardiac Struct Metab 1975;7:249-255.
5. Schelbert HR. Evaluation of "metabolic fingerprints" of myocardial ischemia. Can J Cardiol 1986;(suppl A):121A-130A.
6. Nishimura T. Approaches to identify and characterize hypertrophic myocardium. J Nucl Med 1993;34:1013-1019.
7. Sochor H, Schelbert HR, Schwaiger M, et al. Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy. Eur J Nucl Med 1986;12:566-569.
8. Grover-McKay M, Schwaiger M, Krivokapich J, Perloff JK, Phelps ME, Schelbert HR. Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1989;13:317-324.
9. Kurata C, Kobayashi A, Yamazaki N. Dual tracer autoradiographic study with thallium-201 and radioiodinated fatty acid in cardiomyopathic hamsters. J Nucl Med 1989;30:80-87.
10. Kurata C, Tawarahara K, Taguchi T, et al. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992;33:6-13.
11. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H. Heterogenous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R. S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 1992;29:775-782.
12. Shimonagata T, Nishimura T, Uehara T, et al. Discrepancies between myocardial perfusion and free fatty acid metabolism in patients with hypertrophic cardiomyopathy. Nucl Med Commun 1993;14:1005-1013.
13. Goodman MM, Kirsch G, Knapp FF Jr. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted α-and β-methyl-branched fatty acids. J Med Chem 1984;27:390-397.
14. Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med 1995;36:1022-1030.
15. Tadamura E, Tamaki N, Matsumori A, et al. Myocardial metabolic changes in hypertrophic cardiomyopathy. J Nucl Med 1996;37:572-577.
16. Maron BJ. Asymmetry in hypertrophic cardiomyopathy. The septal to free wall ratio revisited. Am J Cardiol 1985;55:835-858.
17. Shapiro LM, Mckenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 1983;2:437-444.
18. Sahn DJ, Demaria A, Kisslo J, Weyman A. Recommendation regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
19. Yamaguchi H, Ishimura T, Nishiyama S, et al. Hypertrophic nonobstructive cardiomyopathy with giant negative T wave (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979;44:401-412.
20. Maron BJ, Gottidiener JS, Epstein SE. Pattern and significance of distribution of left ventricular hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981;48:418-428.
21. Nienaber CA, Gambhir SS, Mody FV, et al. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation 1993;87:1580-1590.
22. Tamaki N, Tadamura E, Kawamoto M, et al. Decreased uptake of iodinated branched fatty acid analogue indicates metabolic alterations in ischemic myocardium. J Nucl Med 1995;36:1974-1980.
23. Takahashi, N, Tamaki, N, Tadamura, E, et al. Combined assessment of regional perfusion and wall motion in patients with coronary artery disease with technetium-99m-tetrofosmin. J Nucl Cardiol 1994;1:29-38.
24. Tadamura E, Tamaki N, Yonekura Y, et al. Assessment of coronary vasodilator reserve by N-13 ammonia PET using the microsphere method and Patlak plot analysis. Ann Nucl Med 1995;9:109-118.
25. Tadamura E, Tamaki N, Okazawa H, et al. Generator-produced copper-62-PTSM as a myocardial PET perfusion tracer compared with nitrogen-13-ammonia. J Nucl Med 1996;37:729-735.
26. Tamaki N, Magata Y, Takahashi N, et al. Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion. Eur J Nucl Med 1993;20:231-237.
27. Gropler RJ, Siegel BA, Geltman EM. Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med 1991;31:245-251.
28. Brown M, Marshall DR, Sobel BE, Bergmann SR. Delineation of myocardial utilization with carbon-11-labeled acetate. Circulation 1987;76:687-696.
29. 11C] acetate and dynamic positron tomography. Circulation 1989;80:863-872.
30. 11C acetate in patients with old myocardial infarction. Usefulness of low-dose dobutamine infusion. Circulation 1996;94:1834-1841.
31. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron computed tomography: 1. Effect of object size. J Comput Assist Tomogr 1979;3:299-308.
32. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 1986;12:S39-S44.
33. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid. J Nucl Med 1992;33:659-667.
34. Fujibayashi Y, Yonekura Y, Takemura Y, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methyl pentadecanoic acid (BMIPP), in relation to ATP content. J Nucl Med 1990;31:1818-1822.
35. Fujibayashi Y, Som P, Yonekura Y, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methyl pentadecanoic acid (BMIPP), and correlation to ATP concentration II. Studies in salt-induced hypertensive rats. Nucl Med Biol 1992;2:62-66.
36. Kawamoto, M, Tamaki, N, Yonekura, Y, et al. Significance of myocardial uptake of iodine-123-labeled beta-methyl iodophenyl pentadecanoic acid: comparison with kinetics of carbon-11-labeled palmitate in positron emission tomography. J Nucl Cardiol 1994;1:522-528.
37. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med 1994;330:913-919.
38. Tein I, De Vivo DC, Bierman F, et al. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 1990;28:247-255.
39. Stanley CA, Hale DE, Berry GT, Deleeuw S, Boxer J, Bonnefont J-P. A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. N Engl J Med 1992;327:19-23.
40. Hug G, Bove KE, Soukup S. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. N Engl J Med 1991;325:1862-1864.
41. Taroni F, Vederio E, Fiorucci S, et al. Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. Proc Natl Acad Sci USA 1992;89:8429-8433.
42. Hale DE, Batshaw ML, Coates PM, et al. Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatr Res 1985;19:666-671.
43. Rocchiccioli F, Wanders RJA, Auboug P, et al. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 1990;28:657-662.
44. Kusaka Y, Tanaka T, Okamoto F, et al. Effect of sulfo-N-succinimidyl palmitate on the rat heart: myocardial long-chain fatty acid uptake and cardiac hypertrophy. J Mol Cell Cardiol 1995;27:1605-1612.
45. 15O and dynamic positron emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 1988;78:104-115.
46. Bergmann SR, Weinheimer CJ, Markham J, Herrero P. Quantification of myocardial fatty acid metabolism using PET. J Nucl Med 1996;37:1723-1730.
47. 2 inhalation and positron emission tomography. Theory, error analysis, and application in humans. Circulation 1996;94: 792-807.